Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma
Thomas Trian, Giovanni Benard, Hugues Begueret, Rodrigue Rossignol, Pierre-Olivier Girodet, Debajyoti Ghosh, Olga Ousova, Jean-Marc Vernejoux, Roger Marthan, José-Manuel Tunon-de-Lara, Patrick Berger, Thomas Trian, Giovanni Benard, Hugues Begueret, Rodrigue Rossignol, Pierre-Olivier Girodet, Debajyoti Ghosh, Olga Ousova, Jean-Marc Vernejoux, Roger Marthan, José-Manuel Tunon-de-Lara, Patrick Berger
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) are characterized by different patterns of airway remodeling, which all include an increased mass of bronchial smooth muscle (BSM). A remaining major question concerns the mechanisms underlying such a remodeling of BSM. Because mitochondria play a major role in both cell proliferation and apoptosis, we hypothesized that mitochondrial activation in BSM could play a role in this remodeling. We describe that both the mitochondrial mass and oxygen consumption were higher in the BSM from asthmatic subjects than in that from both COPD and controls. This feature, which is specific to asthma, was related to an enhanced mitochondrial biogenesis through up-regulation of peroxisome proliferator-activated receptor gamma coactivator (PGC)-1alpha, nuclear respiratory factor-1, and mitochondrial transcription factor A. The priming event of such activation was an alteration in BSM calcium homeostasis. BSM cell apoptosis was not different in the three groups of subjects. Asthmatic BSM was, however, characterized by increased cell growth and proliferation. Both characteristics were completely abrogated in mitochondria-deficient asthmatic BSM cells. Conversely, in both COPD and control BSM cells, induction of mitochondrial biogenesis reproduced these characteristics. Thus, BSM in asthmatic patients is characterized by an altered calcium homeostasis that increases mitochondrial biogenesis, which, in turn, enhances cell proliferation, leading to airway remodeling.
Figures
References
- Busse, W.W., and R.F. Lemanske Jr. 2001. Asthma. N. Engl. J. Med. 344:350–362.
- Pepe, C., S. Foley, J. Shannon, C. Lemiere, R. Olivenstein, P. Ernst, M.S. Ludwig, J.G. Martin, and Q. Hamid. 2005. Differences in airway remodeling between subjects with severe and moderate asthma. J. Allergy Clin. Immunol. 116:544–549.
- Hogg, J.C., F. Chu, S. Utokaparch, R. Woods, W.M. Elliott, L. Buzatu, R.M. Cherniack, R.M. Rogers, F.C. Sciurba, H.O. Coxson, and P.D. Pare. 2004. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med. 350:2645–2653.
- Lambert, R.K., B.R. Wiggs, K. Kuwano, J.C. Hogg, and P.D. Pare. 1993. Functional significance of increased airway smooth muscle in asthma and COPD. J. Appl. Physiol. 74:2771–2781.
- Johnson, P.R., M. Roth, M. Tamm, M. Hughes, Q. Ge, G. King, J.K. Burgess, and J.L. Black. 2001. Airway smooth muscle cell proliferation is increased in asthma. Am. J. Respir. Crit. Care Med. 164:474–477.
- Roth, M., P.R. Johnson, P. Borger, M.P. Bihl, J.J. Rudiger, G.G. King, Q. Ge, K. Hostettler, J.K. Burgess, J.L. Black, and M. Tamm. 2004. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N. Engl. J. Med. 351:560–574.
- Ramos-Barbon, D., J.F. Presley, Q.A. Hamid, E.D. Fixman, and J.G. Martin. 2005. Antigen-specific CD4+ T cells drive airway smooth muscle remodeling in experimental asthma. J. Clin. Invest. 115:1580–1589.
- Jeffery, P.K. 2001. Remodeling in asthma and chronic obstructive lung disease. Am. J. Respir. Crit. Care Med. 164:S28–S38.
- Springer, J., F.R. Scholz, C. Peiser, D.A. Groneberg, and A. Fischer. 2004. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke. Biol. Chem. 385:649–653.
- Holmuhamedov, E., L. Lewis, M. Bienengraeber, M. Holmuhamedova, A. Jahangir, and A. Terzic. 2002. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J. 16:1010–1016.
- Green, D.R., and G. Kroemer. 2004. The pathophysiology of mitochondrial cell death. Science. 305:626–629.
- Oltersdorf, T., S.W. Elmore, A.R. Shoemaker, R.C. Armstrong, D.J. Augeri, B.A. Belli, M. Bruncko, T.L. Deckwerth, J. Dinges, P.J. Hajduk, et al. 2005. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature. 435:677–681.
- Hackenbrock, C.R., T.G. Rehn, E.C. Weinbach, and J.J. Lemasters. 1971. Oxidative phosphorylation and ultrastructural transformation in mitochondria in the intact ascites tumor cell. J. Cell Biol. 51:123–137.
- Rossignol, R., R. Gilkerson, R. Aggeler, K. Yamagata, S.J. Remington, and R.A. Capaldi. 2004. Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells. Cancer Res. 64:985–993.
- King, M.P., and G. Attardi. 1989. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science. 246:500–503.
- Nisoli, E., S. Falcone, C. Tonello, V. Cozzi, L. Palomba, M. Fiorani, A. Pisconti, S. Brunelli, A. Cardile, M. Francolini, et al. 2004. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc. Natl. Acad. Sci. USA. 101:16507–16512.
- Ebina, M., T. Takahashi, T. Chiba, and M. Motomiya. 1993. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am. Rev. Respir. Dis. 148:720–726.
- Bai, T.R., J. Cooper, T. Koelmeyer, P.D. Pare, and T.D. Weir. 2000. The effect of age and duration of disease on airway structure in fatal asthma. Am. J. Respir. Crit. Care Med. 162:663–669.
- Benard, G., B. Faustin, E. Passerieux, A. Galinier, C. Rocher, N. Bellance, J.P. Delage, L. Casteilla, T. Letellier, and R. Rossignol. 2006. Physiological diversity of mitochondrial oxidative phosphorylation. Am. J. Physiol. Cell Physiol. 291:C1172–C1182.
- Rasmussen, U.F., P. Krustrup, M. Kjaer, and H.N. Rasmussen. 2003. Experimental evidence against the mitochondrial theory of aging. A study of isolated human skeletal muscle mitochondria. Exp. Gerontol. 38:877–886.
- Hansson, A., N. Hance, E. Dufour, A. Rantanen, K. Hultenby, D.A. Clayton, R. Wibom, and N.G. Larsson. 2004. A switch in metabolism precedes increased mitochondrial biogenesis in respiratory chain-deficient mouse hearts. Proc. Natl. Acad. Sci. USA. 101:3136–3141.
- Lehman, J.J., P.M. Barger, A. Kovacs, J.E. Saffitz, D.M. Medeiros, and D.P. Kelly. 2000. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106:847–856.
- Wu, Z., P. Puigserver, U. Andersson, C. Zhang, G. Adelmant, V. Mootha, A. Troy, S. Cinti, B. Lowell, R.C. Scarpulla, and B.M. Spiegelman. 1999. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell. 98:115–124.
- Gleyzer, N., K. Vercauteren, and R.C. Scarpulla. 2005. Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators. Mol. Cell. Biol. 25:1354–1366.
- Nisoli, E., E. Clementi, C. Paolucci, V. Cozzi, C. Tonello, C. Sciorati, R. Bracale, A. Valerio, M. Francolini, S. Moncada, and M.O. Carruba. 2003. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science. 299:896–899.
- Pilz, R.B., and D.E. Casteel. 2003. Regulation of gene expression by cyclic GMP. Circ. Res. 93:1034–1046.
- Miura, S., E. Tomitsuka, Y. Kamei, T. Yamazaki, Y. Kai, M. Tamura,K. Kita, I. Nishino, and O. Ezaki. 2006. Overexpression of peroxisome proliferator-activated receptor gamma co-activator-1alpha leads to muscle atrophy with depletion of ATP. Am. J. Pathol. 169:1129–1139.
- Parenti, A., L. Morbidelli, X.L. Cui, J.G. Douglas, J.D. Hood, H.J. Granger, F. Ledda, and M. Ziche. 1998. Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. J. Biol. Chem. 273:4220–4226.
- Wu, H., S.B. Kanatous, F.A. Thurmond, T. Gallardo, E. Isotani, R. Bassel-Duby, and R.S. Williams. 2002. Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science. 296:349–352.
- Sato, K., A. Suematsu, T. Nakashima, S. Takemoto-Kimura, K. Aoki, Y. Morishita, H. Asahara, K. Ohya, A. Yamaguchi, T. Takai, et al. 2006. Regulation of osteoclast differentiation and function by the CaMK-CREBpathway. Nat. Med. 12:1410–1416.
- Bootman, M.D., and M.J. Berridge. 1995. The elemental principles of calcium signaling. Cell. 83:675–678.
- Massey, K.L., M. Hill, E. Harman, D.R. Rutledge, R. Ahrens, and L. Hendeles. 1988. Dose response of inhaled gallopamil (D600), a calcium channel blocker, in attenuating airway reactivity to methacholine and exercise. J. Allergy Clin. Immunol. 81:912–918.
- Ahmed, T., C.S. Kim, and I. Danta. 1988. Inhibition of antigen-induced bronchoconstriction by a new calcium antagonist, gallopamil: comparison with cromolyn sodium. J. Allergy Clin. Immunol. 81:852–858.
- Hood, D.A. 2001. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. J. Appl. Physiol. 90:1137–1157.
- Global Initiative for Asthma. 1995. Global strategy for asthma management and prevention. NIH publication (updated 2005). .
- Global Initiative for Chronic Obstructive Lung Disease.1998. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NIH publication (updated 2005). .
- Berger, P., P.O. Girodet, H. Begueret, O. Ousova, D.W. Perng, R. Marthan, A.F. Walls, and J.M. Tunon De Lara. 2003. Tryptase-stimulated human airway smooth muscle cells induce cytokine synthesis and mast cell chemotaxis. FASEB J. 17:2139–2141.
- El-Shazly, A., P. Berger, P.O. Girodet, O. Ousova, M. Fayon, J.M. Vernejoux, R. Marthan, and J.M. Tunon-de-Lara. 2006. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J. Immunol. 176:1860–1868.
- Begueret, H., P. Berger, J.M. Vernejoux, L. Dubuisson, R. Marthan, and J.M. Tunon-de-Lara. 2007. Inflammation of bronchial smooth muscle in allergic asthma. Thorax. 62:8–15.
- Trian, T., P.O. Girodet, O. Ousova, R. Marthan, J.M. Tunon-de-Lara, and P. Berger. 2006. RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 34:49–55.
- Berger, P., J.M. Tunon-de-Lara, J.P. Savineau, and R. Marthan. 2001. Tryptase-induced PAR-2-mediated Ca(2+) signaling in human airway smooth muscle cells. J. Appl. Physiol. 91:995–1003.
Source: PubMed